These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28479001)

  • 1. Prophylactic Acetaminophen or Ibuprofen Results in Equivalent Acute Mountain Sickness Incidence at High Altitude: A Prospective Randomized Trial.
    Kanaan NC; Peterson AL; Pun M; Holck PS; Starling J; Basyal B; Freeman TF; Gehner JR; Keyes L; Levin DR; O'Leary CJ; Stuart KE; Thapa GB; Tiwari A; Velgersdyk JL; Zafren K; Basnyat B
    Wilderness Environ Med; 2017 Jun; 28(2):72-78. PubMed ID: 28479001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial.
    Harris NS; Wenzel RP; Thomas SH
    J Emerg Med; 2003 May; 24(4):383-7. PubMed ID: 12745039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness.
    Irons HR; Salas RN; Bhai SF; Gregorie WD; Harris NS
    Wilderness Environ Med; 2020 Mar; 31(1):38-43. PubMed ID: 32057631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
    Hillenbrand P; Pahari AK; Soon Y; Subedi D; Bajracharya R; Gurung P; Lal BK; Marahatta R; Pradhan S; Rai D; Sharma S;
    Wilderness Environ Med; 2006; 17(2):87-93. PubMed ID: 16805144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness.
    Gertsch JH; Corbett B; Holck PS; Mulcahy A; Watts M; Stillwagon NT; Casto AM; Abramson CH; Vaughan CP; Macguire C; Farzan NN; Vo BN; Norvelle RJ; May K; Holly JE; Irons H; Stutz AM; Chapagain P; Yadav S; Pun M; Farrar J; Basnyat B
    Wilderness Environ Med; 2012 Dec; 23(4):307-15. PubMed ID: 23098412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the workload of the two high altitude aid posts in the Nepal Himalayas.
    Basnyat B; Savard GK; Zafren K
    J Travel Med; 1999 Dec; 6(4):217-22. PubMed ID: 10575168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories.
    Lipman GS; Kanaan NC; Holck PS; Constance BB; Gertsch JH;
    Ann Emerg Med; 2012 Jun; 59(6):484-90. PubMed ID: 22440488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Mountain Sickness (AMS) Knowledge Among High Altitude Marathon Runners Competing in the Everest Marathon.
    Letchford A; Paudel R; Thomas OD; Booth AS; Imray CH
    Wilderness Environ Med; 2016 Mar; 27(1):111-6. PubMed ID: 26712333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B; Hulsebosch R; Bosch F
    High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
    McIntosh SE; Hemphill M; McDevitt MC; Gurung TY; Ghale M; Knott JR; Thapa GB; Basnyat B; Dow J; Weber DC; K Grissom C
    Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
    McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B
    Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels.
    Lundeberg J; Feiner JR; Schober A; Sall JW; Eilers H; Bickler PE
    High Alt Med Biol; 2018 Sep; 19(3):249-258. PubMed ID: 29924642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.
    Gertsch JH; Seto TB; Mor J; Onopa J
    High Alt Med Biol; 2002; 3(1):29-37. PubMed ID: 12006162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and Acute Mountain Sickness in Himalayan Trekkers in Nepal: An Observational Cohort Study.
    Duke CB; Sallade TD; Starling J; Pant S; Sheets A; McElwee MK; Young DS; Taylor RA; Keyes LE
    Wilderness Environ Med; 2020 Jun; 31(2):157-164. PubMed ID: 32205041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L; Sherpa C; Nickol A; Windsor J
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G; Keyes LE; Maakestad KM; Olson S; Tissot van Patot MC; Hackett PH
    Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID).
    Lipman GS; Kanaan NC; Phillips C; Pomeranz D; Cain P; Fontes K; Higbee B; Meyer C; Shaheen M; Wentworth S; Walsh D
    High Alt Med Biol; 2015 Jun; 16(2):154-61. PubMed ID: 25950723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.